Aigen Investment Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-8,097
Closed -$125K – 1038
2020
Q3
$125K Buy
+8,097
New +$125K 0.02% 701
2020
Q2
– Sell
-55,749
Closed -$711K – 1262
2020
Q1
$711K Buy
55,749
+55,713
+154,758% +$998K 0.09% 311
2019
Q4
$1K Buy
+36
New +$821 ﹤0.01% 1086

Other funds holding TBI

Aigen Investment Management's TBI Position: Q4 2020 in Review

Aigen Investment Management sold out of Trueblue (TBI) in Q4 2020, closing a stake of 8,097 shares — an estimated $125K sold.

Aigen Investment Management first reported a position in TBI in Q4 2019 and held it in 3 quarters. The position peaked at $711K in Q1 2020. 155 funds tracked by Wall St. Rank hold TBI as of Q4 2020.

  • Aigen Investment Management reported no remaining Trueblue position as of Q4 2020 after selling out during the quarter.
  • Aigen Investment Management sold 8,097 Trueblue shares in Q4 2020, an estimated $125K.
  • Aigen Investment Management first reported a position in Trueblue in Q4 2019 and held it in 3 quarters.
  • Aigen Investment Management's Trueblue position peaked at $711K in Q1 2020.
  • 155 funds tracked by Wall St. Rank held Trueblue as of Q4 2020.

Based on Aigen Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.